MedTrace Logo

A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer

NCT05539144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-05-17

No results posted yet for this study

Summary

The investigators tries a new method to delineating the oral cavity, oropharynx, larynx and hypopharynx, and use the head-and-neck region to test whether the method can to create a good IMRT plan, and alleviate the oral radiation injury, reduce the incidence of adverse reactions.

Conditions

Interventions

RADIATION

"Oropharyngeal mucosa"

"Oropharyngeal mucosa" was delineated as OARs and limiting its dose

RADIATION

oropharynx

oropharynx was delineated as OARs and limiting its dose

RADIATION

oropharynx and "oropharyngeal mucosa"

oropharynx and "oropharyngeal mucosa"were delineated as OARs and limiting its dose

Sponsors & Collaborators

  • Hebei Provincial Hospital of Traditional Chinese Medicine

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2022-12-11
Completion
2023-12-11

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05539144 on ClinicalTrials.gov